World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 7-20 Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7 Therapy of gallstone disease: What it was, what it is, what it will be Piero Portincasa, Agostino Di Ciaula, Leonilde Bonfrate, David QH Wang Piero Portincasa, Leonilde Bonfrate, Department of Biomedical Sciences and Human Oncology, Clinica Medica “A. Murri”, University of Bari Medical […]
Treatment for Gallstones
Alternative non – surgical treatment options summary
Alternative treatment options According to New Zealand Cholecystectomy -Laparoscopic Surgeons and supported by the Heath and Disability Commissioner (gate keeper for patients to sue surgeons for criminal fraud) And in terms of NZ Medical council terms of reference for malpractice : involves immoral, illegal or unethical conduct or neglect of professional duty (improper professional conduct) New Zealand […]
Optimum bile acid treatment for rapid gall stone dissolution
Abstract To determine the optimum bile acid regimen for rapid gail stone dissolution, 48 gall stone patients were divided into four groups of 12 according to stone diameter and were randomly allocated to receive one of four treatment regimens: bedtime or mealtime chenodeoxycholic acid (CDCA, 12 mg/kg/day) and bedtime or mealtime ursodeoxycholic acid (UDCA, 12 […]
Gallbladder Function During Gallstone Dissolution Effect of Bile Acid Therapy in Patients With Gallstones
Gallbladder Function During Gallstone Dissolution Effect of Bile Acid Therapy in Patients With Gallstones In summary, this study demonstrates that treatment with bile acids has a detrimental effect on gallbladder emptying and also on filling in gallstone patients, particularly those who fail to eventually dissolve their stones. No differences in this action were observed between […]
Extracorporeal shockwave lithotripsy of gallstones. Possibilities and limitations.
H Vergunst, O T Terpstra, K Brakel, J S Laméris, M van Blankenstein, and F H Schröder Author information ? Copyright and License information ? Disclaimer This article has been cited by other articles in PMC. Abstract Recently extracorporeal shockwave lithotripsy (ESWL) has been introduced as a nonoperative treatment for gallstone disease. Except for lung damage, no significant adverse effects of ESWL of gallbladder stones […]
Extracorporeal shock wave lithotripsy (ESWL) for difficult bile duct stones: A 15-year single centre experience
Rosangela Muratori, Francesco Azzaroli, Federica Buonfiglioli, Flavio Alessandrelli, Paolo Cecinato, Giuseppe Mazzella, and Enrico Roda Author information ? Article notes ? Copyright and License information ? Disclaimer Abstract AIM: To evaluate the efficacy of extracorporeal shock wave lithotripsy (ESWL) for the management of refractory bile duct cholelithiasis in a third level referral centre. METHODS: The clinical records of all patients treated with a second generation electromagnetic lithotripter […]
Percutaneous cholecystostomy.
Eur J Radiol. 2002 Sep;43(3):229-36. Akhan O1, Akinci D, Ozmen MN. Author information Abstract Percutaneous cholecystostomy (PC), a technique that consists of percutaneous catheter placement in the gallbladder lumen under imaging guidance, has become an alternative to surgical cholecystostomy in recent years. Indications of PC include calculous or acalculous cholecystitis, cholangitis, biliary obstruction and opacification of biliary ducts. […]
Contact dissolution of cholesterol gallstones with organic solvents.
Gastroenterol Clin North Am. 1991 Mar;20(1):183-99. Hofmann AF1, Schteingart CD, vanSonnenberg E, Esch O, Zakko SF. Author information Abstract Contact dissolution of cholesterol gallstones with organic solvents is emerging as a rapid, safe, alternative treatment for symptomatic cholesterol gallbladder stones. Placement of a percutaneous transhepatic catheter into the gallbladder is a rapid and safe technique. The availability of safe, […]
Efficacy and Indications of Ursodeoxycholic Acid Treatment for Dissolving Gallstones A Multicenter Double-Blind Trial
Efficacy and Indications of Ursodeoxycholic Acid Treatment for Dissolving Gallstones A Multicenter Double-Blind Trial TOKYO COOPERATIVE GALLSTONE STUDY GROUP The cholelitholytic action of ursodeoxycholic acid (LJDCA) was investigated by a double-blind clinical trial. The trial started with 153 subjects all confirmed by radiographic examination as having radiolucent gallstones in a functioning gallbladder. The subjects were […]
Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones.
Ann Intern Med. 1982 Sep;97(3):351-6. Tint GS, Salen G, Colalillo A, Graber D, Verga D, Speck J, Shefer S. Abstract Ursodeoxycholic acid, 250 to 300, 500 to 600, or 900 to 1000 mg/d, was given orally for 6 to 38 months to 53 patients with cholesterol gallstones and functioning gallbladders. Forty-two patients had greater than 50% reduction in gallstone volume, number, or […]